BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 36005165)

  • 1. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
    Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
    Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
    Li C; Xu X
    Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
    Wang W; Hao LP; Song H; Chu XY; Wang R
    Front Oncol; 2022; 12():790916. PubMed ID: 35280805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
    Nie G; Lian N; Peng D; Lu J; Li B
    Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
    Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
    Front Immunol; 2022; 13():985815. PubMed ID: 36300115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765.
    Zhuo C; Yi T; Pu J; Cen X; Zhou Y; Feng S; Wei C; Chen P; Wang W; Bao C; Wang J; Tang Q
    Aging (Albany NY); 2020 Dec; 12(24):26236-26247. PubMed ID: 33401249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
    Wu MN; Sun JY; Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.
    Koduru SV; Leberfinger AN; Kawasawa YI; Mahajan M; Gusani NJ; Sanyal AJ; Ravnic DJ
    Sci Rep; 2018 May; 8(1):7967. PubMed ID: 29789629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.
    Khashkhashi Moghadam S; Bakhshinejad B; Khalafizadeh A; Mahmud Hussen B; Babashah S
    J Cell Mol Med; 2022 Jan; 26(2):287-305. PubMed ID: 34907642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
    Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-transmitted long non-coding RNA
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
    Zhao J; Wang Y; Su H; Su L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
    Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
    World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
    Li S; Yao J; Xie M; Liu Y; Zheng M
    J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
    Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
    Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
    Sorop A; Constantinescu D; Cojocaru F; Dinischiotu A; Cucu D; Dima SO
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
    El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
    J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.